About
Ascensia Diabetes Care is a global company based in Basel, Switzerland, focused on enhancing the health and lives of people with diabetes. Established in 2016 after the acquisition of Bayer Diabetes Care, Ascensia builds on over 80 years of innovation in diabetes management, with products available in more than 100 countries. The company specializes in advanced blood glucose monitoring systems and continuous glucose monitoring (CGM) solutions. Its well-known CONTOUR® portfolio includes user-friendly blood glucose meters like CONTOUR®NEXT and BREEZE®, which feature accurate, no-coding technology. Ascensia is also the exclusive global distributor of the Eversense® CGM systems, recognized for their long-lasting implantable technology. Additionally, the GlucoContro.online platform supports data-driven diabetes management for both healthcare professionals and individuals. Through collaborations with various companies, Ascensia aims to enhance diabetes care with integrated solutions and connected technologies.
Technologies
Keywords
Company Information
-
Employees 1500
-
Founded 2016
-
Annual Revenue $410000000
Location
90 Peter Merian-Strasse, Basel, Basel-Stadt, Switzerland, 4052